1nhaler
PrivateLast Round
Seed
Nov 3, 2026
Total Funding Raised
$8.34M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
1nhaler operates in Healthcare & Life Sciences and is based in Edinburgh. Its latest recorded funding round was a Seed round in November 2026.
1nhaler is a medical device company that develops a single-dose, disposable, dry-powder inhaler platform made from cardboard.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
1nhaler Comparables
Compare 1nhaler with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merxin Ltd | 84% | |
| Cambridge Healthcare Innovations | 83% | |
| Iconovo AB | 79% |
For institutional investors. Book with your work email.
1nhaler Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 3, 2026 | ||||
| Seed | Nov 17, 2025 | ||||
| Grant | Jul 1, 2024 | ||||
| Seed | Nov 27, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
1nhaler Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| British Business Bank | Seed |
| Archangel Investors | Seed |
| Scottish Investment Bank (Scottish Enterprise) | Seed, Grant |
| British Business Investments | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 3, 2026
$3M raised with Archangel Investors leading the round.
- Nov 18, 2025
Developing a novel single-dose, pop-up cardboard dry powder inhaler.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingNov 3, 2026
1nhaler receives $2.95M in follow-on funding led by Archangels, with support from Scottish Enterprise and BBB Investments, to advance its cardboard inhaler through technical transfer, clinical trials and regulatory filing in Scotland.
For institutional investors. Book with your work email.
1nhaler Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about 1nhaler's valuation, stock price, and market status.
Is 1nhaler a public or private company?
1nhaler is a private company.
What is the current stock price of 1nhaler?
1nhaler is a private company, so its shares have no public market price. Caplight tracks 1nhaler's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 1nhaler worth (valuation)?
Valuation information for 1nhaler is not publicly available.
Can I buy 1nhaler stock?
1nhaler shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 1nhaler's last funding round?
1nhaler's most recent funding round was Seed on November 3, 2026.
Who are the main investors in 1nhaler?
Key investors in 1nhaler include Archangel Investors.
Will 1nhaler IPO soon?
No public IPO plans have been announced for 1nhaler.
How can I track 1nhaler secondary market activity?
Caplight tracks bids, offers, and trades in 1nhaler's shares on secondary markets.